Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

A Tumor-Targeting Near-Infrared Fluorescent Probe for Real-Time Imaging ATP in Cancer Cells and Mice

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Near-Infrared Fluorescent Nanoprobes for Adenosine Triphosphate-Guided Imaging in Cancer and Fatty Liver Mice

Dual-Stimulus Responsive Near-Infrared Reversible Ratiometric Fluorescent and Photoacoustic Probe for in Vivo Tumor Imaging.

Molecule fluorescent probes for adenosine triphosphate imaging in cancer cells and in vivo

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

A Reversible NIR‐II Ratiometric Fluorescent Probe for Real‐Time In Vivo ATP Detection

NAD(P)H-triggered Probe for Dual-Modal Imaging During Energy Metabolism and Novel Strategy of Enhanced Photothermal Therapy in Tumor.

Enzymatically Controlled DNA Tetrahedron Nanoprobes for Specific Imaging of ATP in Tumor

Ex vivo and in vivo fluorescence detection and imaging of adenosine triphosphate

A Cooperatively Activatable DNA Nanoprobe for Cancer Cell-Selective Imaging of ATP.

Lighting up ATP in cells and tissues using a simple aptamer-based fluorescent probe

A Rapidly Metabolizable and Enzyme-Activated NIR Fluorescent Probe Based on Isophorone for Imaging in Vivo

An Acidic‐Microenvironment‐Driven DNA Nanomachine Enables Specific ATP Imaging in the Extracellular Milieu of Tumor

Universal Near-Infrared Fluorescent Nanoprobes for Detection and Real-Time Imaging of ATP in Real Food Samples, Living Cells, and Bacteria

ATP-triggered highly sensitive probes for super-resolution mitochondrial imaging and low-dose bioimaging

A dual-channel fluorescent nanoprobe for accurate cancer diagnosis by sequential detection of adenosine triphosphate and sulfur dioxide

A Tumor-targetable NIR Probe with Photoaffinity Crosslinking Characteristics for Enhanced Imaging-Guided Cancer Phototherapy

An NIR Fluorescent/photoacoustic Dual-Mode Probe of NADPH for Tumor Imaging

Photoacoustic Imaging of Tumor Targeting with Biotin Conjugated Nanostructured Phthalocyanine Assemblies

A Self-Calibrating Fluorescent-Photoacoustic Integrated Probe Enables Fast Visualizing Pancreatic Cancer and Imaging-Guided Tumor Surgery